cholesterol and t r i g l y c e r i d e s . She a l s o had s y s t o l i c HP, B.P. varying between 140-200 nun Hg. Glucagon s t i mu l a t i o n caused paradoximal hypoglycemia.
Light and e l e c t r o n microscopy of l i v e r biopsy were c o n s i s t e n t w i t h GSD. Enzyme a s s a y s (courtesy of Dr. G. Hug) revealed t h e following: G6-PI--t a s e 5.6 u moles ~/ m i n / g t i s s u e (N = 4.7 5 1 . 9 ) ; l i v e r and musc l e debrancher enzyme was p r e s e n t ; l i v e r phosphorylase was 12.0 u moles P/min/g t i s s u e (N = 2 5 . 1 5 6 . 5 ) ; a c t i v e muscle phosphory l a s e was 9.71 (N = 47.7 + 13.2) and t o t a l muscle phosphorylase was 53.5 (N = 78.0 + 21.1); l i v e r phosphorylase k i n a s e was 0.067 n moles b----)a/min/mg ? r o t . (N = 0.175 + 0.068). Catecholamine s , VMA, HVA, 17-OH, 17-KS, Aldosterone, plasma r e n i n , C c r , I W , and aortogram were a l l normal. At 11 mos. she developed general i z e d xanthomas; serum c h o l e s t e r o l was 906 mg% and t r i g l y c e r i d e s 3620 mg%. C l o f i b r a t e was s t a r t e d and a m n t h l a t e r t h e r e was r e s o l u t i o n of h e r xanthomas w i t h f a l l i n c h o l e s t e r o l t o 259 mg% and t r i g l y c e r i d e s t o 1624 mg%. P r e s e n t l y she i s being maintained on propranolol, diazoxide, a l l o p u r i n o l , Lasix, c l o f i b r a t e . I n summary, our p t . h a s t h e c l i n i c a l p i c t u r e of Type I A o r B GSD but t h e enzyme f i n d i n g s a r e s u g g e s t i v e of Type I X . The HP Previous studies have not clarified.the issue of whether hGH therapy can significantly increase the height of patients with IUGR. In o r d e r to determine whether the initial increase in growth r a t e shown by Foley (J. Pediatr. 84: 635. 1974 ) is sustained through subsequent treatment.
prepubea
NGR patients ( t e r m gestation, height ~4 3 . 7 cm, weight <2kg) were treated with hGH. Ten of them received a second treatment course.
Growth r a t e s in cm/year were 4.8 + 1.4 (mean + SD) f o r the pretreatment period (mean duration 14 months), 7.6 2 2.3 f o r the f i r s t treatment period (mean 13. 7 months), 4.2 + 2.5 for the interval between treatments (mean ll. 1 months), 5 . 9 1 1.4 for the second treatment period (mean 13. 7 months) and 4.3 + 2.6 f o r the post-treatment period (mean 13.6 months). Growth r a t e s f o r the two treatment periods w e r e significantly g r e a t e r than the pre-, interval between, and post-treatment rates. The SD below the mean in height increased significantly between the onset of treatment and the most recent measurement. Sixteen untreated IUGR patients followed for 2 5 y e a r s did not show this difference.
These data indicate that hGH h a s a sustained positive effect on increasing growth r a t e s in children with IUGR, although the magnitude of the effect may decrease with further treatment. Furthermore, with the presently increased availability of hGH, therapy appears to be findicated in children with IUGR.
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-ROMOCRYPTINE (CB-154) THERAPY IN CHILDHOOD ACROMEGAL' lmer S. Lightner, Jeremy S. Winter. U n i v e r s i t y o f r i z o n a , Health Sciences Center, Department of Pediat r i c s , Tucson and University of Manitoba, Winnipeg, Canada.
A 9 2/12 male with McCune-Albright Syndrome and acromegaly (length-178cm) had continued e l e v a t i o n of growth hormone(GH) and p r o l a c t i n ( P r ) d e s p i t e surgery and r a d i a t i o n f o r a P i t u i t a r y Adenoma a t 7 11/12 y r s . He p e r s p i r e d f r e e l y and c o n s t a n t l y needed l a r g e r shoes. H i s continued r a p i d growth(,lOcm/yr) and s e v e r e f i b r o u s d y s p l a s i a led t o r e c u r r e n t p a t h o l o g i c a l f r a c t u r e s of h i s femurs. A 5 mo. t r i a l of CB-154 was i n i t i a t e d . The r e s u l t s of s e q u e n t i a l r e s t i n g GH and P r concentrations and an o r a l glucose t o l e r a n c e t e s t (OGTT) were:
GH(n /ml) P r ( n /ml) OGTT m % P r e CB-154
Post The Johns Hopkins University School of Medicine, Baltimore, Maryland and Washington University School of Medicine, S t . Louis, Missouri.
In t h e syndrome of f a m i l i a l dwarfism with high plasma immunor e a c t i v e growth hormone (GH)(Laron Syndrome), elevated l e v e l s of G H a r e a s s o c i a t e d with low l e v e l s of plasma somatomedin t h a t do not i n c r e a s e following a d m i n i s t r a t i o n of GH. These p a t i e n t s do not respond t o treatment with GH.
The two s u b j e c t s of t h i s r e p o r t were three-year-old boys w i t t dwarfism (height ages 1 3/12 and 1 6/12 y e a r s ) and delayed bone ages ( 1 3/12 and 1 9/12 y e a r s ) . Both had normal GH response a f t e r s t i m u l a t i o n a s s o c i a t e d with undetectable l e v e l s of somatomedin. However, u n l i k e p a t i e n t s with Laron Syndrome, t h e two p a t i e n t s generated normal l e v e l s of somatomedin a f t e r i n t r amuscular a d m i n i s t r a t i o n of GH.
Treatment with G H (2 I U every o t h e r day) brought a s i g n i f i c a n t i n c r e a s e i n t h e growth r a t e of both p a t i e n t s .
The growth r a t e of t h e f i r s t p a t i e n t increased from 2 cmlyear b e f o r e t r e a t m e n t , t o 16 cmlyear on therapy. The growth r a t e o f t h e second p a t i e n t was 4.5 cm/year b e f o r e t r e a tment, and 11.0 cmlyear while on treatment.
The two c a s e s r e p r e s e n t a new syndrome of dwarfism due t o b i o l o g i c a l l y i n a c t i v e , immunoreactive GH.
I f erroneously diagnosed a s having Laron Syndrome, t h e s e p a t i e n t s may be denied t h e b e n e f i t of treatment.
-I

Antibodies t o t h y r o i d cytoplasm (T.C.A.). t o t h y r o i d n u c l e i (ANA) and t o t h y r o g l o b u l i n (T.G.A. ) were determined i n 30
I c h i l d r e n with t h y r o t o x i c o s i s (Tx), i n 1 3 w i t h euthyroid g o i t e r (EG), i n 9 with hypothyroidism and g o i t e r (H.G.) and i n 6 w i t h hypothyroidism w i t h no g o i t e r (HI. H i s t o c o m p a t i b i l i t y (HL-
) a n t i g e n s were a l s o s t u d i e d . The r e s u l t s ( a s p e r c e n t a g e s ) were:
T.G;A. 17 17 0 0 0 1 6 P a t i e n t s with Tx had increased HLA-B8 (45% of c o n t r o l s 25% p <0.05) whereas t h e o t h e r t h y r o i d p a t i e n t s d i d n o t . S i b l i n g s , one with Tx and one with j u v e n i l e d i a b e t e s were ELA i d e n t i c a l (BE+) whereas a n unaffected s i b l i n g shared none of t h e t y p e s .
Families o f Tx had increased Tx, rheumatoid a r t h r i t i s and S.L.E. I n summary, Tx i s s t r o n g l y i n h e r i t e d and r e l a t e d t o HLA;BB. P a t i e n t s w i t h B8 have more T.G.A. and higher t i t e r s of T.C.A., but show l e s s tendency t o r e m i t . W e s p e c u l a t e t h a t Tx a n antibody mediated d i s e a s e and t h y r o i d i t i s a predominantlyce mediated d i s o r d e r .
Supported by NIH g r a n t s AM19286 and AM05745
Lawr ence-; &ollege and Birth Defects I n s t i t u t e , New York h a t e Department of Health, Albanv, New York.
I
In ~e a r n s -s a y r e syndrome (KSS)-( p r o g r e s s i v e e x t e r n a l ophthalmoplegia, pigmentary r e t i n a l degeneration, and h e a r t block) t h e growth f a i l u r e and delayed sexual maturation have not previously been s t u d i e d i n d e t a i l . W e i n v e s t i g a t e d a 15% y e a r old boy with KSS. A CAT scan revealed loss of t h e basal g a n g l i a and of cereb e l l a r white m a t t e r . His bone age was 10 y e a r s . An OGTT was abnormal a t 120 and 180 minutes (161 and 164 mg/dl r e s p e c t i v e l y ) .
The IV GTT was normal: K value 2.31. Thyroid f u n c t i o n was normal i n t h e basal s t a t e ; following TRH, t h e TSH and p r o l a c t i n respons e s were normal, but t h e Ts had not increased by 90 minutes. The growth hormone response was normal t o both i n s u l i n and glucagon. The plasma c o r t i s o l and ACTH showed normal d i u r n a l v a r i a t i o n ; a f t e r r e l e a s e from metapyrone block, n e i t h e r t h e plasma c o r t i s o l nor t h e 17-OH e x c r e t i o n increased a p p r o p r i a t e l y , although t h e \CTH response was normal. The LH, FSH and t e s t o s t e r o n e were norna1 f o r his BA; following t h r e e days of high dose HCG, t h e t e st o s t e r o n e d i d not i n c r e a s e . A f t e r water d e p r i v a t i o n , t h e u r i n a r y ~s m o l a l i t y was 1011 mosmlkg.
Thus i n our p a t i e n t w i t h KSS t h e r e i s evidence t o suggest lac1
~f functional r e s e r v e o r end organ unresponsiveness of t h e thy-*aid, adrenal and t e s t i s ; hypothalamic-pituitary f u n c t i o n appear! to be i n t a c t t o provocative s t i m u l i .
